Send the following on WhatsApp
Continue to ChatThe Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases - https://avesis.omu.edu.tr/yayin/f158d2e9-71d2-4e3a-aea0-53721ccf47e6/the-impact-of-jak1-jak2-inhibitor-ruxolitinib-on-the-spleen-size-and-symptom-burden-in-myeloproliferative-diseases